P10721 (KIT_HUMAN) Homo sapiens (Human)

Mast/stem cell growth factor receptor Kit UniProtKBInterProSTRINGInteractive Modelling

976 aa; Sequence (Fasta) ; (Isoform 2; Isoform 4)

Available Structures

42 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Ectodomain of full-length wild-type KIT-SCF dimers Heteromer
P21583;
35-514
NAG;NAG;
Assess
Crystal structure of the extracellular domain of Kit in complex with stem cell factor (SCF) Heteromer
P21583;
33-507
NAG;
Assess
Ectodomain of full-length KIT(T417I,delta418-419)-SCF dimers Heteromer
P21583;
35-508
NAG;NAG;
Assess
Ectodomain of full-length KIT(DupA502,Y503)-SCF dimers Heteromer
P21583;
35-507
NAG;NAG;
Assess
Crystal structure of KIT D4D5 fragment in complex with anti-Kit antibody Fab19 Heteromer
310-508
NAG;
Assess
Crystal structure of KIT D4D5 fragment in complex with anti-Kit antibodies Fab79D Heteromer
311-509
NAG;
Assess
Crystal structure of SOCS6 SH2 domain in complex with a c-KIT phosphopeptide Heteromer
O14544;
566-574
EDO;
Assess
Crystal structure of the PI3-kinase p85 N-terminal SH2 domain in complex with c-Kit phosphotyrosyl … Heteromer
P27986;
718-725
Assess
KIT kinase domain mutant D816H in complex with sunitinibhomo-4-mer564-930
B49;SO4;
Assess
Crystal structure of human c-KIT kinase domain in complex with compound 15ahomo-2-mer554-931
DJX;
Assess
Crystal structure of unactivated c-KIT in complex with compoundhomo-2-mer563-932
AWO;
Assess
Crystal structure of activated c-KIT in complex with compoundhomo-2-mer569-935
AWO;
Assess
Structural basis of KIT activation by oncogenic mutations in the extracellular region reveals a zip…homo-2-mer309-506
NAG;CO;
Assess
Crystal structure of the exctracellular domain of the receptor tyrosine kinase, Kitmonomer11-508
NAG;
Assess
STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASEmonomer547-935
Assess
KIT kinase domain in complex with sunitinibmonomer544-931
B49;
Assess
Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX3397monomer547-931
P31;
Assess
Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX647monomer551-931
647;
Assess
Identification of M4205 a highly selective inhibitor of cKIT mutations for unresectable metastatic …monomer554-932
K3R;
Assess
Identification of M4205 a highly selective inhibitor of cKIT mutations for unresectable metastatic …monomer557-932
KCI;
Assess
STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASEmonomer565-933
PO4;STI;
Assess
Crystal structure of KIT in complex with ponatinibmonomer565-933
0LI;PO4;
Assess
c-KIT kinase domain in complex with avapritinib derivative 9monomer566-932
9OO;
Assess
c-KIT kinase domain in complex with avapritinib derivative 10monomer566-931
9VV;
Assess
c-KIT kinase domain in complex with avapritinibmonomer566-931
9JI;
Assess
c-KIT kinase domain in complex with avapritinib derivative 12monomer566-931
9KI;
Assess
Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX9486 (bezuclastinib) in …monomer566-931
WEJ;
Assess
c-KIT T670I mutated kinase domain in complex with avapritinibmonomer566-931
9JI;
Assess
Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX8512 in the DFG-in statemonomer566-931
WEG;
Assess
Crystal structure of the kinase domain of human c-KIT in complex with a type-II inhibitormonomer566-931
O35;
Assess
c-KIT kinase domain in complex with avapritinib derivative 4monomer566-930
98A;
Assess
c-KIT kinase domain in complex with avapritinib derivative 8monomer567-931
9XO;
Assess
c-KIT kinase domain in complex with avapritinib derivative 11monomer566-930
EDO;9WU;BR;
Assess
Structure of c-Kit with allosteric inhibitor 3G8monomer565-929
PO4;G4E;
Assess
Crystal structure of human c-KIT kinase domain in complex with AZD3229-analogue (compound 23)monomer567-931
F88;
Assess
Crystal structure of human c-KIT kinase domain in complex with AZD3229-analogue (compound 18)monomer567-931
F82;
Assess
Crystal structure of KIT1 in complex with DP2976 via co-crystallizationmonomer567-930
14×NO3;JWY;
Assess
Crystal structure of human c-KIT kinase domain in complex with AZD3229-analogue (compound 35)monomer568-931
F8B;
Assess
Crystal structure of human c-KIT kinase domain in complex with a small molecule inhibitor, AZD3229monomer569-931
F8H;CL;
Assess
Crystal structure of the kinase domain of human c-KIT with a cyclic imidate inhibitor covalently bo…monomer569-931
O2H;
Assess
Crystal structure of the kinase domain of human c-KIT in complex with a type-II inhibitor bearing a…monomer569-931
O2K;
Assess
Structure of a c-Kit Kinase Product Complexmonomer567-927
MG;ADP;
Assess

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8dfm.1.Amonomer0.7539-514
99.89
Assess
3krl.1.Amonomer0.62552-926
KRL;67.79
Assess
8jot.1.Amonomer0.62550-928
65.59
Assess

4 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 28dfm.1.Amonomer0.7636-510
99.89
Assess
Isoform 28jot.1.Amonomer0.63546-924
65.59
Assess
Isoform 23krl.1.Amonomer0.62548-922
KRL;68.10
Assess
Isoform 41t45.1.Amonomer0.8212-215
85.29
Assess